Forschungsprojekte
Ergebnisse pro Seite:
25
2019 - 2022
RAPTOR: An Eighteen-Month, Two-Arm, Randomized, Double-- PD Dr. Dr. KatrinLorenz,
- Dr. Bert ConstantinGiers,
- Dr. AnnaBeck
2019 - 2020
Efficacy and safety assessment of T4032 (unpreserved bimatoprost 0.01%)- PD Dr. Dr. KatrinLorenz
2019 - 2023
Keratoconjunctivitis Sicca: The importance of protein glycosylation for tear film stability- Prof. Dr. Dr. FranzGrus,
- Univ.-Prof. Dr. NorbertPfeiffer
2019 - 2022
EyeBIS Study: The interdisciplinary prospective clinicial trial evaluating the influence of general anaesthesia on intraocular pressure- Univ.-Prof. Dr. Esther M.Hoffmann,
- Dr. NinaPirlich
2018 - 2021
Effect of a combination of unpreserved trehalose and sodium hyaluron on the tear proteome in patients with dry eye disease- Prof. Dr. Dr. FranzGrus
2018 - 2022
Measurement of novel tear fluid biomarkers in increasingly prevalent retinal eye diseases: Improving diagnostic in AMD, DR/DME and glaucoma- Prof. Dr. Dr. FranzGrus
2018 - 2020
INCB 54828-201: A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations- Prof. Dr. IgorTsaur,
- PD Dr. ThomasHöfner,
- PD Dr. WolfgangJäger
2018 - 2019
FORT-1:Phase 2/3 study of rogaratinib (BAY 1163877) vs chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma- Prof. Dr. GeorgBartsch,
- Prof. Dr. IgorTsaur,
- PD Dr. ThomasHöfner
2018 - 2022
FORT-2: Phase 1b/2 study of rogaratinib (BAY 1163877) in combination with atezolizumab in urothelial carcinoma- Prof. Dr. GeorgBartsch,
- Prof. Dr. IgorTsaur,
- PD Dr. ThomasHöfner
2018 - 2019
Characterization of the functional role(s) of proline-rich protein 4 (PRR4) in ameliorating dry eye disease in an in vitro hyperosmotic human corneal epithelial cell model- Dr. NatarajanPerumal,
- Prof. Dr. Dr. FranzGrus